Drug-Induced Movement Disorders

Download PDF

All antipsychotic drugs, first generation and second generation, block a chemical in the brain called dopamine. Blocking dopamine raises the chance of drug-induced movement side effects.

  1. Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biological Psychiatry. 2013 Feb;14(1):2-44. Informa UK Limited; 2013 Feb. DOI: 10.3109/15622975.2012.739708.
  2. Crespo-Facorro B, Pérez-Iglesias R, Mata I, Caseiro O, Martínez-Garcia O, Pardo G, et al. Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine. J Psychiatric Res. 2011 Jun;45(6):763-769. Elsevier BV; 2011 Jun. DOI: 10.1016/j.jpsychires.2010.11.002.
  3. Moore TA, Buchanan RW. The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia. J Clin Psychiatry. 2007 Nov 15;68(11):1751-1762. Physicians Postgraduate Press, Inc; 2007 Nov 15. DOI: 10.4088/jcp.v68n1115.
  4. Lewis R. Chemical Reactions. Physical Science I. 1978;:133-145. London: Macmillan Education UK; 1978. DOI: 10.1007/978-1-349-02823-8_11; ISBN: 9780333192191.
  5. Dadiomov D. What you need to know about tardive dyskinesia (TD). AAPP. [cited 2021Nov1].
  6. Albanese A, Bhatia K, Bressman SB, DeLong MR, Fahn S, Fung VSC, et al. Phenomenology and classification of dystonia: A consensus update. Mov Disord. 2013 Jun 15;28(7):863-873. Wiley; 2013 Jun 15. DOI: 10.1002/mds.25475.
  7. Changing epidemiology of tardive dyskinesia: an overview. AJP. 1981 Mar 1;138(3):297-309. American Psychiatric Association Publishing; 1981 Mar 1. DOI: 10.1176/ajp.138.3.297.
  8. Fernandez HH, Friedman JH. CLASSIFICATION AND TREATMENT OF TARDIVE SYNDROMES. Neurologist. 2003 Jan;9(1):16-27. Ovid Technologies (Wolters Kluwer Health); 2003 Jan. DOI: 10.1097/01.nrl.0000038585.58012.97.
  9. Tarsy D, Baldessarini RJ. Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics?. Mov Disord. 2006 May;21(5):589-598. Wiley; 2006 May. DOI: 10.1002/mds.20823.